health
By Brendan O’Brien
(Reuters) – Officials in Rolling Fork on Monday mobilized volunteers, organized logistics and opened a mobile hospital in the impoverished small town in western Mississippi clobbered by a ferocious tornado three days ago.
Some 26 people were killed in the powerful twister that ripped...
Read More
Arkansas governor signs school bathroom bill into law
LITTLE ROCK, Ark. (AP) — Arkansas Gov. Sarah Huckabee Sanders on Tuesday signed a law prohibiting transgender people at public schools from using the restroom that matches their gender identity, the first of several states expected to enact such bans this year amid a flood of...
Read More
FDA advisers back Pfizer COVID treatment for full approval
(Reuters) – Advisers to the U.S. Food and Drug Administration on Thursday overwhelmingly backed Pfizer’s oral antiviral COVID-19 treatment Paxlovid for full approval in adults at high risk of progression to severe disease.
The FDA’s panel of outside experts...
Read More
health Headlines
- UnitedHealth insurance unit to cut use of prior authorization process
WHO urges Equatorial Guinea to report additional Marburg cases- Factbox-First RSV vaccines inch closer to the finish line
- WHO to consider adding obesity drugs to ‘essential’ medicines list
- Exclusive-WHO to consider adding obesity drugs to ‘essential’ medicines list
- US FDA approves first OTC opioid overdose reversal drug
- Exclusive-ICU Medical to compete against GE Healthcare for Medtronic units -sources
- US FDA approves first OTC opioid overdose reversal drug
- J&J bows out of RSV vaccine race after scrapping trial
- J&J bows out of RSV vaccine race after scrapping trial
- US FDA approves first OTC opioid overdose reversal drug
- J&J bows out of RSV vaccine race after scrapping trial
- J&J bows out of RSV vaccine race after scrapping trial
- US FDA approves first OTC opioid overdose reversal drug
- Exclusive-WHO to consider adding obesity drugs to ‘essential’ medicines list
- US FDA approves first OTC opioid overdose reversal drug
- Carl Icahn wants to bring back Illumina’s ex-CEO -WSJ
- Exclusive-Ramsay, Sime Darby plan to revive sale of Asia healthcare venture- sources
- Exclusive-WHO to consider adding obesity drugs to ‘essential’ medicines list
- Exclusive-WHO to consider adding obesity drugs to ‘essential’ medicines list
- Exclusive-WHO to consider adding obesity drugs to ‘essential’ medicines list
- WHO revises COVID-19 vaccine recommendations for Omicron-era
- WHO revises COVID-19 vaccine recommendations for Omicron-era
- WHO revises COVID-19 vaccine recommendations for Omicron-era
- Viking joins obesity drug race after promising early trial data
- Viking joins obesity drug race after promising early trial data
- WHO revises COVID-19 vaccine recommendations for Omicron-era
- Oscar Health names former Aetna head Mark Bertolini as CEO
- U.S. FDA panel to discuss Perrigo’s daily OTC birth-control pill in May
- WHO changes COVID vaccine recommendations
- WHO changes COVID vaccine recommendations
- Oscar Health names former Aetna head Mark Bertolini as CEO
- Viking Therapeutics obesity drug shows promise in early-stage study, shares soar
- Oscar Health names former Aetna head Mark Bertolini as CEO
- Viking Therapeutics to start obesity drug mid-stage trial
- Australian engineers create ‘flexible robot’ for 3D printing inside the body
- Australian engineers create ‘flexible robot’ for 3D printing inside the body
- Amgen-Sanofi patent case divides makers of antibody drugs
- Amgen-Sanofi patent case divides makers of antibody drugs
- Amgen-Sanofi patent case divides makers of antibody drugs
- Amgen-Sanofi patent case divides makers of antibody drugs
- Novartis buoyed by trial success in early-stage breast cancer
- Cigna’s PBM, two others sued in Ohio over drug price fixing
- CVS expects to close $8 billion Signify deal this week
- U.S. Supreme Court mulls Amgen bid to revive cholesterol drug patents
- Cigna’s PBM, two others sued in Ohio over drug price fixing – WSJ
- Cigna’s PBM, two others sued in Ohio over drug price fixing – WSJ
- U.S. Supreme Court mulls Amgen bid to revive cholesterol drug patents
- Jounce dumps Redx Pharma for acquisition by Concentra; to cut 84% of jobs
- Cash-rich BioNTech plans to spend about $1 billion more on research this year
